A
EW icon

Argentarii’s Edwards Lifesciences EW Stock Holding History

Argentarii’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$749K Sell
7,998
-2,680
-25% -$225K 0.23% 88
2026
Q1 		$855K Sell
10,678
-2,814
-21% -$232K 0.3% 77
2025
Q4 		$1.15M Sell
13,492
-524
-4% -$43K 0.37% 61
2025
Q3 		$1.09M Buy
14,016
+3,109
+29% +$243K 0.43% 50
2025
Q2 		$853K Sell
10,907
-1,825
-14% -$136K 0.39% 61
2025
Q1 		$923K Buy
12,732
+9,280
+269% +$664K 0.46% 58
2024
Q4 		$256K Buy
+3,452
New +$242K 0.13% 129

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Argentarii's EW Position: Q2 2026 in Review

Argentarii reduced its Edwards Lifesciences (EW) stake by 25% in Q2 2026, selling an estimated $225K and leaving 7,998 shares worth $749K. The position accounts for 0.23% of the portfolio, ranked #88.

Argentarii first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.15M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Argentarii held 7,998 shares of Edwards Lifesciences worth $749K as of Q2 2026.
  • Argentarii sold 2,680 Edwards Lifesciences shares in Q2 2026, an estimated $225K.
  • Edwards Lifesciences made up 0.23% of Argentarii's portfolio in Q2 2026, its #88 holding.
  • Argentarii first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • Argentarii's Edwards Lifesciences position peaked at $1.15M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Argentarii's 13F filing for Q2 2026, filed 12 Aug 2026.